These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30538722)

  • 1. Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.
    Rana A; Thakur S; Kumar G; Akhter Y
    Front Genet; 2018; 9():572. PubMed ID: 30538722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.
    Schussek S; Trieu A; Doolan DL
    Biotechnol Adv; 2014; 32(2):403-14. PubMed ID: 24389084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing the next generation of vaccines for global public health.
    Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
    OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reverse vaccinology: strategy against emerging pathogens].
    Monterrubio-López GP; Delgadillo-Gutiérrez K
    Rev Med Inst Mex Seguro Soc; 2021 Aug; 59(3):233-241. PubMed ID: 34370422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systems biology perspective on rational design of peptide vaccine against virus infections.
    Chen J; Wang Y; Guo D; Shen B
    Curr Top Med Chem; 2012; 12(12):1310-9. PubMed ID: 22690678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
    Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
    J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
    Seib KL; Zhao X; Rappuoli R
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology.
    Rizwan M; Naz A; Ahmad J; Naz K; Obaid A; Parveen T; Ahsan M; Ali A
    BMC Bioinformatics; 2017 Feb; 18(1):106. PubMed ID: 28193166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches and omics tools for mining of vaccine candidates against vector-borne diseases.
    Kuleš J; Horvatić A; Guillemin N; Galan A; Mrljak V; Bhide M
    Mol Biosyst; 2016 Aug; 12(9):2680-94. PubMed ID: 27384976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery.
    Dalsass M; Brozzi A; Medini D; Rappuoli R
    Front Immunol; 2019; 10():113. PubMed ID: 30837982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse vaccinology.
    Mora M; Veggi D; Santini L; Pizza M; Rappuoli R
    Drug Discov Today; 2003 May; 8(10):459-64. PubMed ID: 12801798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies for screening protective viral antigens and their applications in the development of novel vaccines].
    Zhong D; Wang T; Luo R; Qiu HJ; Sun Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Aug; 38(8):2857-2871. PubMed ID: 36002415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-based vaccine design: the promise for malaria and other infectious diseases.
    Doolan DL; Apte SH; Proietti C
    Int J Parasitol; 2014 Oct; 44(12):901-13. PubMed ID: 25196370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.